BACKGROUND: Institut Georges Lopez-1 (IGL-1) is a preservation solution similar to University of Wisconsin (UW) with reversed Na/K contents. In this study, we assessed the impact of IGL-1, UW, and Celsior (CS) solutions on islet isolation and transplant outcome. METHODS: We retrospectively analyzed 376 islet isolations from pancreases flushed and transported with IGL-1 (n=95), UW (n=204), or CS (n=77). We determined isolation outcome and β-cell function in vitro. Transplanted patients were divided into three groups depending on preservation solution of pancreas, and islet graft function was assessed by decrease in daily insulin needs, C-peptide/glucose ratios, β-scores, and transplant estimated function at 1- and 6-month follow-up. RESULTS: IGL-1, UW, and CS groups were similar according to donor age, body mass index, and pancreas weight. There was no difference in islet yields between the three groups. Success rates, transplant rates, β-cell secretory function, and viability were similar for all three groups. We observed no difference in decreased insulin needs, C-peptide glucose ratios, β-scores, and transplant estimated function at 1- and 6-month follow-up between IGL-1, UW, and CS groups. CONCLUSIONS: Our study shows that IGL-1 is equivalent to UW or CS solutions for pancreas perfusion and cold storage before islet isolation and transplantation.
BACKGROUND: Institut Georges Lopez-1 (IGL-1) is a preservation solution similar to University of Wisconsin (UW) with reversed Na/K contents. In this study, we assessed the impact of IGL-1, UW, and Celsior (CS) solutions on islet isolation and transplant outcome. METHODS: We retrospectively analyzed 376 islet isolations from pancreases flushed and transported with IGL-1 (n=95), UW (n=204), or CS (n=77). We determined isolation outcome and β-cell function in vitro. Transplanted patients were divided into three groups depending on preservation solution of pancreas, and islet graft function was assessed by decrease in daily insulin needs, C-peptide/glucose ratios, β-scores, and transplant estimated function at 1- and 6-month follow-up. RESULTS: IGL-1, UW, and CS groups were similar according to donor age, body mass index, and pancreas weight. There was no difference in islet yields between the three groups. Success rates, transplant rates, β-cell secretory function, and viability were similar for all three groups. We observed no difference in decreased insulin needs, C-peptide glucose ratios, β-scores, and transplant estimated function at 1- and 6-month follow-up between IGL-1, UW, and CS groups. CONCLUSIONS: Our study shows that IGL-1 is equivalent to UW or CS solutions for pancreas perfusion and cold storage before islet isolation and transplantation.
Authors: Stephen Harrington; S Janette Williams; Vern Otte; Sally Barchman; Cheryl Jones; Karthik Ramachandran; Lisa Stehno-Bittel Journal: BMC Vet Res Date: 2017-08-22 Impact factor: 2.741
Authors: Daniel Brandhorst; Géraldine Parnaud; Andrew Friberg; Vanessa Lavallard; Sandrine Demuylder-Mischler; Stephen Hughes; Julia Saphörster; Manfred Kurfürst; Olle Korsgren; Thierry Berney; Paul R V Johnson Journal: Cell Transplant Date: 2017-10 Impact factor: 4.064
Authors: Joana Ferrer-Fàbrega; Emma Folch-Puy; Juan José Lozano; Pedro Ventura-Aguiar; Gabriel Cárdenas; David Paredes; Ángeles García-Criado; Josep Antoni Bombí; Rocío García-Pérez; Miguel Ángel López-Boado; Ramón Rull; Enric Esmatjes; Maria José Ricart; Fritz Diekmann; Constantino Fondevila; Laureano Fernández-Cruz; Josep Fuster; Juan Carlos García-Valdecasas Journal: Transpl Int Date: 2022-03-28 Impact factor: 3.782